Introduction
Rabishield is a medication that contains Rabies Human Monoclonal Antibody as its active ingredient. It is available in an injectable form and is primarily used for the prevention and treatment of rabies.
Uses
Rabishield is prescribed for individuals who have been exposed to the rabies virus or have a high risk of exposure. It is used to provide passive immunity by neutralizing the rabies virus and preventing its spread in the body. It is an essential component of rabies post-exposure prophylaxis and is administered along with other preventive measures, such as wound cleaning and vaccination.
Dosage and Administration
Rabishield should be administered by a healthcare professional. The dosage and administration may vary depending on the individual’s age, weight, and the severity of the exposure. It is typically given as a single dose via intramuscular or intravenous injection. The exact dosage and administration instructions should be provided by the healthcare professional based on the specific situation.
Mechanism of Action
Rabies Human Monoclonal Antibody in Rabishield works by binding to the rabies virus and neutralizing its harmful effects. It prevents the virus from entering and infecting cells, thereby reducing the risk of rabies development. By providing immediate passive immunity, this medication gives the body time to develop its own active immune response through vaccination.
Side Effects
Common side effects may include injection site reactions, such as pain, redness, or swelling. Serious side effects are rare but can include allergic reactions. Seek immediate medical attention if you experience any signs of an allergic reaction, such as difficulty breathing, rash, or swelling of the face, lips, tongue, or throat.
Drug Interactions
inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products. There are no known significant drug interactions with Rabishield. However, it is always best to consult with your healthcare professional to ensure the safe use of this medication.
Precautions
Before using Rabishield, inform your healthcare professional about any allergies you may have, especially to any components of the medication. Discuss your medical history, including any previous reactions to rabies vaccinations or other immune globulin treatments. Rabishield is generally considered safe for use during pregnancy and breastfeeding. However, consult with your healthcare professional before use.
Storage
Patient Tips
- Follow the dosage and administration instructions provided by your healthcare professional.
- Report any side effects or concerns to your healthcare professional.
- Keep track of the date and time of administration to ensure timely follow-up doses if required.
- Store the medication properly in the refrigerator as instructed.
- Do not use the medication if it appears cloudy, discolored, or contains particles.
- Seek immediate medical attention if you experience signs of an allergic reaction after receiving the injection.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Vaccinations (NHS UK) [Accessed 11 Jun. 2024] (online) Available at:
- Haemoctin (Health Professionals SmPC) Available at:
- Sars-cov-2 (covid-19) vaccine, adenovirus 26 vector (janssen) Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 4 Jun. 2024] (online) Available at:
- cinqair 10 mg/ml intravenous solution monoclonal antibody, human interleukin 5 antagonist (RX) [Accessed 28 Jun. 2024] (online) Available at:
- HCG in urine (MedlinePlus) [Accessed 23 Jun. 2024] (online) Available at:
- Majhen D. Human adenovirus type 26 basic biology and its usage as vaccine vector. Rev Med Virol. 2022 Nov;32(6):e2338. doi: 10.1002/rmv.2338. Epub 2022 Mar 12. [Accessed 6 Jun. 2024] Available at:
Reviews
There are no reviews yet.